The new version of the GMP standard is about to announce the low price transfer of pharmaceutical companies
Release time: 2010-07-21 & nbsp & nbsp & nbsp Source:
After the new version of the GMP standard is announced，Fifty pharmaceutical factories in the country may be eliminated，The transfer of medical assets will be more intense
At present, a trend of low premium transfer is quietly rising.
The reporter found in the recent real estate right trading markets，Many pharmaceutical companies currently trading trading，Most of the transfer of equity or property rights，But the valuation of the transfer price is generally low，What's more, choose discount or 1 yuan transfer treatment due to shortage of funds。
Reporters found on the website of the Beijing Property Exchange，3.346%of Xiamen Beida Road Biological Engineering Co., Ltd., which was just listed on July 5th, was transferred at 3.346%of the equity of only 4.7 million yuan;，The Dezhou Finance Bureau will be listed for transfer of 36%of the Dezhou Pharmaceutical Co., Ltd. (hereinafter referred to as Texas Pharmaceuticals) held at the price of 36%of the State Pharmaceutical Co., Ltd.，Evaluation value compared to the equity of 28.888 million yuan，The premium is only 3.4%; the Changchun High -tech subsidiary of Changchun High -tech Holding Subsida, a subsidiary of Changguang stake betting appPharmaceutical, stake betting appwhich is publicly listed on the Jilin Changchun Property Rights Trading Center，The transfer price is 5.5 million yuan，At present, it has been confirmed to be transferred to Jilin Huakang Pharmaceutical Co., Ltd., a subsidiary of Changchun High -tech subordinates;，The transfer price is only 2.9 million yuan。
Low premium due to poor performance
Reporter discovered，June 8，Tsinghua Holdings Co., Ltd. in Beijing's property rights transaction, so the price of 1 yuan is transferred to the loss subsidiary Beijing Ziguang Pharmaceutical Co., Ltd. 100%equity，The minimum price of the transfer of pharmaceutical assets during this period。It is reported，As of May 27, 2010，The total assets of Ziguang Pharmaceutical are 290 million yuan，But liabilities are as high as 355 million yuan，Net assets are -64.83 million yuan，So，The corresponding evaluation value of this transfer target is -58.91 million yuan，and the listing price is symbolic as 1 yuan。
"Most of the currently transferred asset equity is a general operating performance，or because of the exit of the state -owned enterprise's divestiture and state -owned equity，So the transfer price of listing is generally low。"Some analysts think，The performance of Texas Pharmaceuticals should be the reason for the low premium of this transfer。It is reported，According to Texas Medicine Finance data, it is displayed，As of September 30, 2009，Company's assets totaling 58.106 million yuan，The owner's equity is 57.8368 million yuan。Reporter noticed，The first three quarters of 2009 and the first two months of this year，The company's operating income is zero，The net profit is not optimistic。
And a Jiangxi Golden Key Pharmaceutical Co., Ltd. (hereinafter referred to as Jin Key Pharmaceutical Industry Co., Ltd. (hereinafter referred to as Jin Key Pharmaceutical), which is planned to be transferred by the Jiangxi Provincial Property Rights Exchange Jingdezhen Haihong Real Estate Co., Ltd.，Listed for only 35 million yuan，Stake Sports BettingThis My stake betting apptransfer price compared to the company's net assets of 69.73 million yuan，Equivalent to nearly 50 % off transfer。
The person in charge of the transfer project said，At present, the human and material resources of Jin Key Pharmaceuticals are relatively complete，But the biggest problem facing is the urgent lack of funds，So，This listing hopes to make up for the company's cash flow。"The current company's situation can be said to be‘ everything is ready，Only owed funds'，So，In the requirements of the transferee，Good financial resources are the most important。"Golden Key Pharmaceuticals particularly emphasized the financial strength of the transferee，and indicate that there are basically not many conditions in other aspects of the transferee，The reason is that the company's own talent reserves of the drug、Factory equipment and other aspects already have conditions。
Founded in 2001，and Shizhen Pavilion、Shuangye、Mike pharmacy together，Known as Chongqing's "Four Private Pharmacy"。Due to excessive expansion and sudden credit，2007 fund chain broke，Sardved investors to seek reorganization。2007，Real Estate owner of Banan District Tu Xinfu takes over，Now liquidation to debt for debt。A few days ago，Chongqing City Stock Exchange is commissioned by the court，On June 29th, a public auction of 5 real estate, including Chongqing Quanfa Pharmaceutical Headquarters，The reference price of the listing total is 40.14 million yuan。
Preferred peers
As one of the important ways to withdraw as a state -owned equity，The "seller" of the pharmaceutical bids traded in various real estate rights also has many national teams。Reporter discovered，State -owned equity transfer usually requires higher requirements for "lower home"，Conditions for the transferee，It is also more favored by companies in the industry。
Although the operating performance is not ideal，But Tsinghua Holdings has issued a "harsh" condition to the transferee: the intention of the intention must be a state -owned My stake betting appstake online sports bettingenterprise with a legal registration of more than 1 year in China、State -owned Holdings or Enterprises，The proportion of state -owned equity is not less than 40%; the intention to be transferee or its major shareholders (the shareholding ratio of not less than 40%) must have at least one party must have the investment management experience of pharmaceutical enterprises，And there are medical listed companies; the registered capital of the intention of the intention is not less than 100 million yuan。In addition，The target company as of December 31, 2009 owed the transferor and its affiliated companies a total of 325 million yuan，The intention of the intention must make a written commitment: the company's successful company will repay the above debt within five years。
From the perspective of the transfers of Texas Medicine，Transfer Fang Dezhou Finance Bureau clearly stated that it is more popular with R & D strength、Pharmaceutical industry enterprises for production chemical preparations，Promise it has the right to give priority under the same conditions。In addition，It also puts forward the following conditions for the transferee: first of all, you need to pay the equity transfer price at one time; second，The transferee must promise，After receiving the equity of the transfer，The registered address of the company without changing the target; the third is that the transferee must guarantee the equity of the transfer，The target enterprise continues to undertake the original debt and debt of the enterprise and may have liabilities，Perform all the economic contracts that the company originally signed。
Transfer of the Golden Key Pharmaceuticals of the Jiangxi Provincial Property Exchange，The transferor also puts forward the requirements of the assignee that needs to be in the industry: First, the transferee must have a good financial payment ability: the second is that the assignee must ensure that the company must not be migrated to production in 5 years，Guarantee employees of the target enterprise My stake betting appstake sports betting appwill not be laid within 3 years。"This transfer has a large extent to increase the color of local employment。"Some analysts said that。
Shen Yin Wanuo analysts believe，The new version of GMP (drug production quality management specifications) standards for 5 years may be announced this month，The necessary production access conditions for the pharmaceutical industry，The new version of GMP will be in the device、Plant and other hardware and production process management and other software propose higher requirements，It is expected that the pharmaceutical industry will invest 50 billion yuan for GMP transformation，There will be 500 pharmaceutical factories nationwide or will be eliminated due to failure to meet the standard。At that time, more pharmaceutical assets may be listed in various real estate trading markets。
At present, a trend of low premium transfer is quietly rising.
The reporter found in the recent real estate right trading markets，Many pharmaceutical companies currently trading trading，Most of the transfer of equity or property rights，But the valuation of the transfer price is generally low，What's more, choose discount or 1 yuan transfer treatment due to shortage of funds。
Reporters found on the website of the Beijing Property Exchange，3.346%of Xiamen Beida Road Biological Engineering Co., Ltd., which was just listed on July 5th, was transferred at 3.346%of the equity of only 4.7 million yuan;，The Dezhou Finance Bureau will be listed for transfer of 36%of the Dezhou Pharmaceutical Co., Ltd. (hereinafter referred to as Texas Pharmaceuticals) held at the price of 36%of the State Pharmaceutical Co., Ltd.，Evaluation value compared to the equity of 28.888 million yuan，The premium is only 3.4%; the Changchun High -tech subsidiary of Changchun High -tech Holding Subsida, a subsidiary of Changguang stake betting appPharmaceutical, stake betting appwhich is publicly listed on the Jilin Changchun Property Rights Trading Center，The transfer price is 5.5 million yuan，At present, it has been confirmed to be transferred to Jilin Huakang Pharmaceutical Co., Ltd., a subsidiary of Changchun High -tech subordinates;，The transfer price is only 2.9 million yuan。
Low premium due to poor performance
Reporter discovered，June 8，Tsinghua Holdings Co., Ltd. in Beijing's property rights transaction, so the price of 1 yuan is transferred to the loss subsidiary Beijing Ziguang Pharmaceutical Co., Ltd. 100%equity，The minimum price of the transfer of pharmaceutical assets during this period。It is reported，As of May 27, 2010，The total assets of Ziguang Pharmaceutical are 290 million yuan，But liabilities are as high as 355 million yuan，Net assets are -64.83 million yuan，So，The corresponding evaluation value of this transfer target is -58.91 million yuan，and the listing price is symbolic as 1 yuan。
"Most of the currently transferred asset equity is a general operating performance，or because of the exit of the state -owned enterprise's divestiture and state -owned equity，So the transfer price of listing is generally low。"Some analysts think，The performance of Texas Pharmaceuticals should be the reason for the low premium of this transfer。It is reported，According to Texas Medicine Finance data, it is displayed，As of September 30, 2009，Company's assets totaling 58.106 million yuan，The owner's equity is 57.8368 million yuan。Reporter noticed，The first three quarters of 2009 and the first two months of this year，The company's operating income is zero，The net profit is not optimistic。
And a Jiangxi Golden Key Pharmaceutical Co., Ltd. (hereinafter referred to as Jin Key Pharmaceutical Industry Co., Ltd. (hereinafter referred to as Jin Key Pharmaceutical), which is planned to be transferred by the Jiangxi Provincial Property Rights Exchange Jingdezhen Haihong Real Estate Co., Ltd.，Listed for only 35 million yuan，Stake Sports BettingThis My stake betting apptransfer price compared to the company's net assets of 69.73 million yuan，Equivalent to nearly 50 % off transfer。
The person in charge of the transfer project said，At present, the human and material resources of Jin Key Pharmaceuticals are relatively complete，But the biggest problem facing is the urgent lack of funds，So，This listing hopes to make up for the company's cash flow。"The current company's situation can be said to be‘ everything is ready，Only owed funds'，So，In the requirements of the transferee，Good financial resources are the most important。"Golden Key Pharmaceuticals particularly emphasized the financial strength of the transferee，and indicate that there are basically not many conditions in other aspects of the transferee，The reason is that the company's own talent reserves of the drug、Factory equipment and other aspects already have conditions。
Founded in 2001，and Shizhen Pavilion、Shuangye、Mike pharmacy together，Known as Chongqing's "Four Private Pharmacy"。Due to excessive expansion and sudden credit，2007 fund chain broke，Sardved investors to seek reorganization。2007，Real Estate owner of Banan District Tu Xinfu takes over，Now liquidation to debt for debt。A few days ago，Chongqing City Stock Exchange is commissioned by the court，On June 29th, a public auction of 5 real estate, including Chongqing Quanfa Pharmaceutical Headquarters，The reference price of the listing total is 40.14 million yuan。
Preferred peers
As one of the important ways to withdraw as a state -owned equity，The "seller" of the pharmaceutical bids traded in various real estate rights also has many national teams。Reporter discovered，State -owned equity transfer usually requires higher requirements for "lower home"，Conditions for the transferee，It is also more favored by companies in the industry。
Although the operating performance is not ideal，But Tsinghua Holdings has issued a "harsh" condition to the transferee: the intention of the intention must be a state -owned My stake betting appstake online sports bettingenterprise with a legal registration of more than 1 year in China、State -owned Holdings or Enterprises，The proportion of state -owned equity is not less than 40%; the intention to be transferee or its major shareholders (the shareholding ratio of not less than 40%) must have at least one party must have the investment management experience of pharmaceutical enterprises，And there are medical listed companies; the registered capital of the intention of the intention is not less than 100 million yuan。In addition，The target company as of December 31, 2009 owed the transferor and its affiliated companies a total of 325 million yuan，The intention of the intention must make a written commitment: the company's successful company will repay the above debt within five years。
From the perspective of the transfers of Texas Medicine，Transfer Fang Dezhou Finance Bureau clearly stated that it is more popular with R & D strength、Pharmaceutical industry enterprises for production chemical preparations，Promise it has the right to give priority under the same conditions。In addition，It also puts forward the following conditions for the transferee: first of all, you need to pay the equity transfer price at one time; second，The transferee must promise，After receiving the equity of the transfer，The registered address of the company without changing the target; the third is that the transferee must guarantee the equity of the transfer，The target enterprise continues to undertake the original debt and debt of the enterprise and may have liabilities，Perform all the economic contracts that the company originally signed。
Transfer of the Golden Key Pharmaceuticals of the Jiangxi Provincial Property Exchange，The transferor also puts forward the requirements of the assignee that needs to be in the industry: First, the transferee must have a good financial payment ability: the second is that the assignee must ensure that the company must not be migrated to production in 5 years，Guarantee employees of the target enterprise My stake betting appstake sports betting appwill not be laid within 3 years。"This transfer has a large extent to increase the color of local employment。"Some analysts said that。
Shen Yin Wanuo analysts believe，The new version of GMP (drug production quality management specifications) standards for 5 years may be announced this month，The necessary production access conditions for the pharmaceutical industry，The new version of GMP will be in the device、Plant and other hardware and production process management and other software propose higher requirements，It is expected that the pharmaceutical industry will invest 50 billion yuan for GMP transformation，There will be 500 pharmaceutical factories nationwide or will be eliminated due to failure to meet the standard。At that time, more pharmaceutical assets may be listed in various real estate trading markets。
